Skip to main content
Clinical Trials/NCT02656823
NCT02656823
Completed
N/A

Implant-fixed Restorations With Short Implants in the Edentulous Maxilla - A Clinical Investigation Over a 5-year Follow-up Period

Dentsply Sirona Implants and Consumables1 site in 1 country12 target enrollmentNovember 24, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Edentulous Maxilla
Sponsor
Dentsply Sirona Implants and Consumables
Enrollment
12
Locations
1
Primary Endpoint
Implant Survival Rate
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Study to assess the performance of six short implants (ANKYLOS C/X 6.6 mm) in the edentulous maxilla supporting fixed full-arch bridges after 5 years in function.

Detailed Description

Study to assess the performance of six short implants (ANKYLOS C/X 6.6 mm) in the edentulous maxilla supporting fixed full-arch bridges after 5 years in function. The primary objective was to evaluate implant survival.

Registry
clinicaltrials.gov
Start Date
November 24, 2015
End Date
December 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Dentsply Sirona Implants and Consumables
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Implant Survival Rate

Time Frame: At Visit 14, 5 years after permanent restoration (PR).

Any implant that is removed after implant placement will be considered failure, whatever reason for removal. Implant survival will be evaluated clinically and radiographically by counting the number of remaining implants.

Secondary Outcomes

  • At Least One Surface With Plaque.(At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Oral Health Impact Profile 14 (OHIP-14)(At pre-surgical planning (Visit 2) on average 6 months before PR, and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Mean Marginal Bone Level (MBL) at Subject's Tissue Level(At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 1-year after PR (Visit 10), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Any Bleeding on Implant (BoP)(At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Mean Probing Pocket Depth (PPD) at Subject Level.(At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 6-months after PR (Visit 9), at 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Implant Stability(At implant placement (IP) (Visit 3), and at Abutment surgery and Impression (Visit 5, at 13 weeks after IP).)
  • Prosthetic Survival Rate on Subject Level(At 1-year after PR (Visit 10), at 2-years after PR (Visit 11), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)
  • Mean Marginal Bone Level (MBL) on Implant Level.(At permanent restoration (PR) (Visit 8, at 17 weeks after IP), and at 1-year after PR (Visit 10), at 3-years after PR (Visit 12), and at 5-years after PR (Visit 14).)

Study Sites (1)

Loading locations...

Similar Trials